Latest News

Filters

Filter by tags: Australia Netherlands Clear all tag filters

8 news articles found

The Critical Design Review for Argentina's CAREM small modular reactor should be completed within 60 days, the new president of the National Atomic Energy Commission (CNEA), Germán Guido Lavalle, has said.

Source: World Nuclear News
Date: Saturday, 01 June 2024
Original article: world-nuclear-news.org/Articles/Critical-Design-Review-for-Argentina-s-CAREM-small

EU supply agency also warns of continued dependence on Moscow for VVER nuclear fuel

Source: Nucnet
Date: Friday, 20 October 2023
Original article: nucnet.org/news/97-of-europe-s-natural-uranium-comes-from-overseas-but-russia-deliveries-fall-10-4-2023

The UK’s Nuclear Transport Solutions (NTS), part of the Nuclear Decommissioning Authority (NDA), is collaborating with renewable marine technology specialist Smart Green Shipping (SGS) to investigate retrofitting new sail technology on its specialist nuclear transport ships. SGS is developing unique FastRig retrofit sails and sustainable technology for commercial ships.

Source: NEI Magazine
Date: Wednesday, 14 June 2023
Original article: neimagazine.com/news/newsuk-nuclear-shipping-may-go-green-10935045

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

An International Atomic Energy Agency (IAEA) Integrated Regulatory Review Service (IRRS) mission said Slovakia is committed to maintaining and strengthening its regulatory framework for nuclear and radiation safety, as the it prepares to start up a third reactor unit at the Mochovce NPP.  The team also noted areas where it could be further enhanced, for example by increasing coordination between different national authorities involved in regulatory oversight.

Source: NEI Magazine
Date: Saturday, 24 September 2022
Original article: neimagazine.com/news/newsiaea-says-slovakia-is-committed-to-a-high-level-of-safety-10031124

A group of 46 non-governmental organisations (NGOs) from 18 countries has written to Ursula von der Leyen, president of the European Commission, calling for the inclusion of nuclear energy in the EU taxonomy for sustainable investments. The exclusion of nuclear, they say, would promote a strategy that is "clearly inadequate" to decarbonise the region's economy.

Source: World Nuclear News
Date: Thursday, 08 April 2021
Original article: world-nuclear-news.org/Articles/NGOs-call-for-nuclears-inclusion-in-EU-taxonomy

Agency schedules webinar and warns of possible shortages at hospitals A researcher at Indonesia’s National Nuclear Agency using a hot cell to prepare a radiopharmaceutical. Courtesy M. Gaspar/IAEA. The production of radioisotopes used to produce radiopharmaceuticals for medical procedures has continued during the Covid-19 pandemic, but hospitals could face shortages due to bottlenecks in transport and distribution, the International Atomic Energy Agency has warned.

An agency survey conducted among operators of research reactors that produce radioisotopes for radiopharmaceuticals shows that most major actors continue to produce radioisotopes because the production facilities have been defined as essential by the relevant governments.

However, many airlines are no longer operating because of the pandemic and borders are closed, which affects the distribution of medical radioisotopes around the world.

Joao Osso Junior, head of the radioisotope products and radiation technology section at the IAEA, said the agency is working to assess the need for medical radioisotopes because most research and education activities using isotopes have been put on hold and many hospitals have delayed diagnosis applications.

Source: Nucnet
Date: Wednesday, 22 April 2020
Original article: nucnet.org/news/radioisotope-industry-facing-distribution-challenges-says-iaea-4-2-2020

The production of medical radioisotopes has continued during the COVID-19 pandemic but bottlenecks in transport and distribution could lead to shortages at hospitals, according to an International Atomic Energy Agency (IAEA) survey of the research reactors where the isotopes are produced.

Source: World Nuclear News
Date: Wednesday, 22 April 2020
Original article: world-nuclear-news.org/Articles/Medical-isotope-supply-chain-faces-challenges-from